{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:38:49Z","timestamp":1788565129033,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jns.2024.123059","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:21:11Z","timestamp":1716484871000},"page":"123059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases"],"prefix":"10.1016","volume":"462","author":[{"given":"Lorenzo","family":"Barba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Oeckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Chiasserini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Gaetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo Guido","family":"Torrigiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico Paolini","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Steinacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Abu-Rumeileh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Parnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2024.123059_bb0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2024.123059_bb0010","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/gps.3881","article-title":"Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies","volume":"28","author":"Brunnstr\u00f6m","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jns.2024.123059_bb0015","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1212\/WNL.0000000000005166","article-title":"CSF tau and \u03b2-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders","volume":"90","author":"Irwin","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123059_bb0020","article-title":"A\/T\/(N) profile in cerebrospinal fluid of Parkinson\u2019s disease with\/without cognitive impairment and dementia with Lewy bodies","volume":"10","author":"Bellomo","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jns.2024.123059_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acn3.697","article-title":"Antemortem CSF A\u03b242\/A\u03b240 ratio predicts Alzheimer\u2019s disease pathology better than A\u03b242 in rapidly progressive dementias","volume":"6","author":"Baiardi","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2024.123059_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2010.10.015","article-title":"High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal \u03b2-amyloid in Parkinson disease","volume":"487","author":"Compta","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2024.123059_bb0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","article-title":"Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes","volume":"129","author":"Walker","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2024.123059_bb0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.parkreldis.2020.09.030","article-title":"Prevalence and clinical associations of tau in Lewy body dementias: a systematic review and meta-analysis","volume":"80","author":"Chin","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2024.123059_bb0045","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","article-title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","volume":"17","author":"Hampel","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2024.123059_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2741\/1778","article-title":"Neuroserpin","volume":"11","author":"Galliciotti","year":"2006","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jns.2024.123059_bb0055","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1007\/s00018-021-03907-6","article-title":"Neuroserpin: structure, function, physiology and pathology","volume":"78","author":"D\u2019Acunto","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jns.2024.123059_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab261","article-title":"VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases","volume":"3","author":"Quinn","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.jns.2024.123059_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194674","article-title":"VGF peptides in cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"20","author":"van Steenoven","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2024.123059_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00388-2","article-title":"Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach","volume":"15","author":"Van Steenoven","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jns.2024.123059_bb0075","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/mds.28704","article-title":"CSF protein level of neurotransmitter secretion, synaptic plasticity, and autophagy in PD and DLB","volume":"36","author":"Lerche","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2024.123059_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-59414-4","article-title":"Cerebrospinal fluid proteomics implicates the granin family in Parkinson\u2019s disease","volume":"10","author":"Rotunno","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2024.123059_bb0085","doi-asserted-by":"crossref","first-page":"29268","DOI":"10.1074\/jbc.M600690200","article-title":"Neuroserpin binds A\u03b2 and is a neuroprotective component of amyloid plaques in Alzheimer disease","volume":"281","author":"Kinghorn","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jns.2024.123059_bb0090","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1471-4159.2011.07359.x","article-title":"Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer\u2019s disease transgenic mouse model","volume":"118","author":"Fabbro","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2024.123059_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1471-4159.2009.05894.x","article-title":"Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain","volume":"109","author":"Fabbro","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2024.123059_bb0100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1582-4934.2011.01394.x","article-title":"Activators and inhibitors of the plasminogen system in Alzheimer\u2019s disease","volume":"16","author":"Barker","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jns.2024.123059_bb0105","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1212\/01.wnl.0000271077.82508.a0","article-title":"Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies","volume":"69","author":"Nielsen","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123059_bb0110","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2024.123059_bb0115","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2024.123059_bb0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies fourth consensus report of the DLB consortium","volume":"89","author":"Mckeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123059_bb0125","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2024.123059_bb0130","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society task force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2024.123059_bb0135","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mds.22017","article-title":"The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson\u2019s disease","volume":"23","author":"Gill","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2024.123059_bb0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2024.123059_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.647783","article-title":"Machine learning driven profiling of cerebrospinal fluid Core biomarkers in Alzheimer\u2019s disease and other neurological disorders","volume":"15","author":"Bellomo","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jns.2024.123059_bb0150","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1212\/WNL.0000000000207371","article-title":"CSF synaptic biomarkers in AT(N)-based subgroups of Lewy body disease","volume":"101","author":"Barba","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123059_bb0155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.jns.2024.123059_bb0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2024.123059_bb0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2024.123059_bb0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jns.2024.123059_bb0175","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123059_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229345","article-title":"A solution to minimum sample size for regressions","volume":"15","author":"Jenkins","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2024.123059_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081930","article-title":"Neuroinflammation and alzheimer\u2019s disease: a machine learning approach to csf proteomics","volume":"10","author":"Gaetani","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jns.2024.123059_bb0190","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jns.2024.123059_bb0195","article-title":"Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson\u2019s disease","volume":"3","author":"Karayel","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jns.2024.123059_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neurobiolaging.2022.07.015","article-title":"CSF peptides from VGF and other markers enhance prediction of MCI to AD progression using the ATN framework","volume":"121","author":"Llano","year":"2023","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2024.123059_bb0205","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3233\/JAD-180855","article-title":"Improved differential diagnosis of Alzheimer\u2019s disease by integrating elisa and mass spectrometry-based cerebrospinal fluid biomarkers","volume":"67","author":"Khoonsari","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2024.123059_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09613-z","article-title":"Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age","volume":"10","author":"Wingo","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jns.2024.123059_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/s12014-020-09276-9","article-title":"A comprehensive systematic review of CSF proteins and peptides that define Alzheimer\u2019s disease","volume":"17","author":"Pedrero-Prieto","year":"2020","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.jns.2024.123059_bb0220","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","article-title":"Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression","volume":"105","author":"Bai","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2024.123059_bb0225","article-title":"Deciphering cellular transcriptional alterations in Alzheimer\u2019s disease brains","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jns.2024.123059_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17405-z","article-title":"Multiscale causal networks identify VGF as a key regulator of Alzheimer\u2019s disease","volume":"11","author":"Beckmann","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jns.2024.123059_bb0235","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1469-7580.2010.01309.x","article-title":"Distribution of VGF peptides in the human cortex and their selective changes in Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"217","author":"Cocco","year":"2010","journal-title":"J. Anat."},{"key":"10.1016\/j.jns.2024.123059_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23136922","article-title":"Specific cerebrospinal fluid SerpinA1 isoform pattern in Alzheimer\u2019s disease","volume":"23","author":"Barba","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2024.123059_bb0245","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/acn3.50980","article-title":"CSF SerpinA1 in Creutzfeldt\u2013Jakob disease and frontotemporal lobar degeneration","volume":"7","author":"Abu-Rumeileh","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2024.123059_bb0250","article-title":"Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer\u2019s disease","author":"Massa","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2024.123059_bb0255","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41597-023-02158-3","article-title":"Quantitative mass spectrometry analysis of cerebrospinal fluid protein biomarkers in Alzheimer\u2019s disease","volume":"10","author":"Watson","year":"2023","journal-title":"Sci. Data"},{"key":"10.1016\/j.jns.2024.123059_bb0260","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-017-0335-x","article-title":"Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer\u2019s disease","volume":"10","author":"Duits","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jns.2024.123059_bb0265","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/mds.29044","article-title":"Sex differences for clinical correlates of Alzheimer\u2019s pathology in people with Lewy body pathology","volume":"37","author":"Bayram","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2024.123059_bb0270","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1111\/ene.15801","article-title":"Sex hormones differentially contribute to Parkinson disease in males: a multimodal biomarker study","volume":"30","author":"Bovenzi","year":"2023","journal-title":"Eur. J. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24001941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24001941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T10:57:49Z","timestamp":1728039469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24001941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":54,"alternative-id":["S0022510X24001941"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123059","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123059"}}